Participation and adherence to cardiac rehabilitation programs. A systematic review

Alberto Ruano-Ravina1, Carlos Pena-Gil2, Emad Abu-Assi2

  • 1Department of Preventive Medicine & Public Health, University of Santiago de Compostela, Santiago de Compostela, Spain; Consortium for Biomedical Research in Epidemiology & Public Health (CIBER en Epidemiología y Salud Pública - CIBERESP), Spain.

Insights

Participation in cardiac rehabilitation (CR) programs after acute myocardial infarction (AMI) is influenced by patient demographics and program accessibility. Understanding these factors is key to improving CR program engagement and effectiveness.

Area of Science:

  • Cardiology
  • Public Health
  • Rehabilitation Medicine

Background:

  • Acute myocardial infarction (AMI) poses a significant health burden globally.
  • Cardiac rehabilitation (CR) programs are proven to reduce mortality post-AMI.
  • Identifying barriers to CR participation and adherence is crucial for optimizing patient outcomes.

Purpose of the Study:

  • To systematically review factors influencing participation and adherence to CR programs following AMI.
  • To synthesize findings from existing literature on CR engagement.
  • To identify demographic and logistical factors affecting CR program uptake and consistency.

Main Methods:

  • Systematic literature review of Medline, EMBASE, and Cochrane databases (2004-2016).
  • Inclusion and exclusion criteria applied to select relevant studies.
  • Classification of identified factors into those affecting participation and adherence.

Main Results:

  • 29 studies were included, showing consistent factors affecting CR participation and adherence.
  • Person-related factors (age, gender, comorbidities, socioeconomic status, education, marital status) significantly impact engagement.
  • Program-related factors (distance to facility, transportation availability) also influence attendance and adherence.
  • Findings were consistent across Europe and the USA, indicating a homogeneous pattern.

Conclusions:

  • Participation and adherence to CR programs follow predictable patterns, influenced by patient characteristics and program accessibility.
  • Healthcare professionals should tailor communication and program design to address identified barriers.
  • Interventions aimed at improving CR engagement are needed to enhance post-AMI recovery and reduce mortality.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
363
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
582
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
501
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
453
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
726
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.4K